Adequate management for various problems of geriatric syndrome in elder diabetic patients by Bando, Hiroshi
Submit Manuscript | http://medcraveonline.com
Abbreviations: LCD, low carbohydrate diet;  JLCDPA, Japan 
low carbohydrate diet promotion association; ACP, American college 
of physicians; PEM, protein energy malnutrition; MACE, major 
adverse cardiovascular events; ESPEN,  European society for clinical 
nutrition and metabolism
Commentary 
In recent years, the population of the elderly people has increased 
across the world. Thus, ageing population has been recently highlighted 
for the importance of medical care. Specifically, it is necessary to 
evaluate not only physical function, but also psychological/ mental/ 
cognitive function. Furthermore, appropriate diet and exercise therapy 
has to be given according to each medical and health situation. In this 
article, various problems related to the elderly patients with diabetes 
will be discussed. 
The most important feature in elderly patients with diabetes 
has been the frequent occurrence of geriatric syndrome.1 This is 
comprised of a variety of problems including dementia, flailty, 
sarcopenia, impaired ADL /QOL, falls, malnutrition, depression, 
urinary incontinence, multiple medications, and so on. 
In particular, diabetes has a high risk of causing Alzheimer’s 
disease, vascular dementia, total dementia and mild cognitive 
impairment (MCI).2 The result of risk ratio for each state is 1.46, 
2.49, 1.51 and 1.22, respectively.2 Among these, self-care disorders 
have been observed because their memory and executive functions 
have been impaired. Therefore, it is important to evaluate cognitive 
function for elderly patients with diabetes. However, the screening is 
not so easy procedure in the actual clinical setting.
Furthermore, sarcopenia and flail have been crucial problems 
related to body function. Sarcopenia has been found in 15% of 
diabetic patients, which shows 2-3 times more frequent presence 
than that in non-diabetic patients.3 Diabetes shows several impaired 
or decreased physical functions, such as walking speed, lower limb 
muscle strength and muscle quality.4–7 Consequently, diabetes seems 
to be characteristic of generally decreased muscle function.5,6
In 2018, the European Working Group on Sarcopenia in Older 
People (EWGSOP) announced a new diagnostic standard guideline 
(EWGSOP 2).8 It evaluates muscle weakness with emphasis on grip 
strength or required time to get up from a chair. In fact, there was an 
increased risk of death and cardiovascular mortality in diabetic patients 
with reduced grip strength.8 Muscular strength would be emphasized 
rather than muscle volume for the evaluation of sarcopenia in the 
future. 
As to the therapy for sarcopenia and flail, adequate nutrition 
intake has been deemed necessary. The European Society for Clinical 
Nutrition and Metabolism (ESPEN) proposed the standard nutritional 
recommendations for several situations.9 They suggest that i) healthy 
older people take at least 1.0-1.2 g protein/kg body weight/day, ii) 
older people with malnutrition are given 1.2-1.5 g protein/kg body 
weight/day, and iii) all of the elderly should have daily physical 
activity or exercise (resistance training, aerobic exercise) for as long 
as possible.9  
  In general, the characteristic of malnutrition in the elderly is 
protein energy malnutrition (PEM).10 In the case of patients with 
elderly patients with diabetes and/or sarcopenia obesity, increased 
energy intake leads to increased carbohydrate intake. Therefore, 
there would be the risk of unstable glucose variability, weight control 
deterioration and decreased ADL/QOL states. Consequently, an 
approach to reduce energy and increase protein intake seems to be 
necessary for the actual situation. 
From the above, low carbohydrate diet (LCD) could be one of the 
recommended methods for treating such patients. The authors have 
continued clinical practice and research of LCD for years, and have 
shown the efficacy of LCD rather than calorie restriction (CR).11 
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Abstract
Diabetes in elderly patients has frequent occurrence of geriatric syndrome. It includes a 
variety of problems among which the following can be cited, dementia, flaity, sarcopenia, 
impaired ADL / QOL, falls, malnutrition, depression, urinary incontinence, multiple 
medications, and so on. Risk ratio of total dementia is 1.51. Elderly patients with diabetes 
have sarcopenia 2-3 times more frequently than that of non-diabetic patients. In elderly 
patients with diabetes, sarcopenia obesity, low carbohydrate diet (LCD) can become an 
option for adequate nutritional treatment. American College of Physicians (ACP) presented 
a Guidance Statement Update in 2018, associated with the recommendation of weaker strict 
control. ACP guidance was summarized by evaluating four mega diabetic studies, including 
ACCORD, ADVANCE, UKPDS33/34 and VADT. When managing elderly patients with 
diabetes, comprehensive evaluation of various factors would be important for the happiness 
of the patient. 
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We have introduced three types of actual LCD methods, which are 
super LCD, standard LCD and petite LCD with 12%, 26%, 40% of 
carbohydrate involvement, respectively.12,13 Furthermore, we have 
developed medical and social movement for LCD through various 
activity of the Japan Low Carbohydrate Diet Promotion Association 
(JLCDPA). 
Concerning exercise therapy for diabetics, resistance exercise and 
multicomponent exercise are important. In particular, multicomponent 
exercise intervention could reverse frailty and improve cognition, 
emotional, and social networking in the community-dwelling 
elderly frail people.14 Moreover, there was a study of the Lifestyle 
Interventions and Independence for Elders (LIFE) trial which was 
set up as a randomized controlled clinical trial. As a result, elderly 
patients with diabetes improved both the physical ability and the 
cognitive function.15 The crucial point seems to be how to incorporate 
multi-element movements.
As regards to the diabetic control by the biomarker of hemoglobin 
A1c (HbA1c) indicating  of the amount of blood glucose attached 
to haemoglobin, American Diabetes Association (ADA) had 
recommended lower HbA1c value for better diabetic control for long 
period. On the other hand, American College of Physicians (ACP) 
presented a Guidance Statement Update in 2018, associated with the 
recommendation of weaker strict control.16 The review was conducted 
from 6 main mega studies. Their recommended targets of HbA1c in 
6 studies are summarized as follows: i) AACE/ACE: < 6.5% if safe 
situation, ii) ADA: <7.0% generally, but < 6.5% or 8.0% possible in 
various cases, iii) ICSI: < 8.0% and < 7.0% is too strict, iv) NICE: 
< 6.5% without meds, < 7.0% with 1 med, <7.5% with more than 2 
meds, v) SIGN: < 7.0% with individualization, vi) Va/DoD: < 7.0% 
without complications, 7.0-8.5% with complications, 8.0-9.0% in 
severe prognosis. 
The ACP guidance was summarized by evaluating four 
megadiabetic studies.16 They included ACCORD, ADVANCE, 
UKPDS33/34 and VADT.17–21 From these results, maintaining HbA1c 
value less than 7.0% has not reduced the events for macrovascular 
complications, death, or severe microvascular complications. On 
the other hand, intensive therapy has caused severe hypoglycemia, 
death, weight gain and so on. These were the fundamental data of the 
evidence for the guidance.
ACP showed the relative lack of the evidence in the range of HbA1c 
6.5-7.0%. On the other hand, J-DOIT3 conducted in Japan targets the 
range of HbA1c 6.5-7.0%.22 Compared to the conventional therapy 
group (<6.9%), the intensive therapy group (<6.2%) showed superior 
evidence. The effect on each endpoint was -58% for cerebrovascular 
events, -24% for primary endpoints, -32% for nephropathy events, 
and -14% for retinopathy events (each p <0.01).22
Regarding the relationship between glucose level and risk of major 
adverse cardiovascular events (MACE), there was a significant study.23 
The hazard ratio for MACE and cumulative glycemic exposure of 
protection of CVD events were investigated. As a result, the duration 
of the intensification of glycemic control would be crucial factor for 
protection of CVD events.23 
Recently, the European Endocrine Society and The Gerontological 
Society of America jointly published the guidelines for elderly patients 
with diabetes.24 Its goal was to provide the guidance to practicing 
health care providers which benefit diabetic patients associated with 
attention to avoiding unnecessary adverse effects. Among them, a 
lower limit was set when using anti-diabetic agents that easily cause 
hypoglycemia. This policy would affect the actual treatment situation 
of elderly patients with diabetes in Europe.24 
In summary, various symptoms and complications are observed in 
elderly patients with diabetes. The principle of treatment direction is 
always the same regardless of the diseased condition. However, it will 
be important to comprehensively evaluate the age, severity of illness, 
complication states, previous treatment period, probable effects, and 
to induce them toward treatments that increase their happiness. 
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